Eva M. Jager
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Multistep pathogenesis of chronic myelomonocytic leukemia in patients.
Journal: European journal of haematology
Published: January 06, 2022
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.
Journal: European journal of haematology
Published: March 02, 2021
Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival.
Journal: European journal of haematology
Published: September 18, 2020
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia.
Journal: International journal of molecular sciences
Published: July 26, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
Journal: International journal of molecular sciences
Published: April 05, 2020
Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia.
Journal: Leukemia research reports
Published: May 06, 2019
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.
Journal: Wiener klinische Wochenschrift
Published: April 04, 2019
The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia.
Journal: British journal of haematology
Published: February 22, 2017
Last Updated: 09/26/2026